On July 26, 2026, clinical researchers in Canada published a patient navigation report on sourcing advanced oncology therapies during local stock fluctuations. Navigating access to critical monoclonal antibodies like Herceptin (Trastuzumab) 660mg Injection and immunotherapies like Keytruda (Pembrolizumab) 100mg Injection is a priority for Canadian clinical teams managing complex cancer cases.

At Critical Kare Pharma, we cooperate with Canadian clinical networks to deliver authentic, cold-chain monitored biologics. Sourcing through validated international wholesale channels ensures treatment plans can proceed without interruption from regional stock shortages.

Biological Integrity & Temperature Control

• Monoclonal Antibody Heat Sensitivity: Both Trastuzumab and Pembrolizumab are large biological proteins that will lose potency if exposed to temperatures outside the 2–8°C range.
• How to Use & Administer Herceptin 660mg: Given as a ready-to-use subcutaneous injection in the thigh over 2–5 minutes. It should not be mixed or diluted with other medications.
• How to Use & Administer Keytruda 100mg: Diluted and administered as a 30-minute intravenous infusion. It requires aseptic preparation in a clinical pharmacy.
• Validated Shipping Logistics: Deliveries to Canadian cities (Toronto, Vancouver, Montreal, Calgary) utilize high-performance thermal insulation and data loggers to record temperature every single minute of transit.

Health Canada Import Sourcing Regulations

Health Canada regulations permit individuals to import up to a 90-day supply of prescription drugs for personal use under specific conditions, requiring a valid prescription from a licensed Canadian physician. Critical Kare Pharma handles all customs declarations, clearance protocols, and batch verification documents (COA) to ensure seamless delivery to Canadian patients and healthcare facilities.